Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.55 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.55 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.55 |
| ▸ | TLR2 | O60603 | 4/20 | 0.46 |
| ▸ | TERT | O14746 | 5/20 | 0.45 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.44 |
| ▸ | RRM1 | P23921 | 1/20 | 0.43 |
| ▸ | CD40 | P25942 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | NOS1 | P29475 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 1/20 | 0.39 |
| ▸ | CHRNA1 | P02708 | 2/20 | 0.39 |
| ▸ | CHRNG | P07510 | 2/20 | 0.39 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.39 |
| ▸ | CHRND | Q07001 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18653794 | 1.00 | GNAI3 (0.55) | GNAI3GNAO1GNAI1TLR2TERT | |
| SCHEMBL14239755 | 1.00 | GNAI3 (0.55) | GNAI3GNAO1GNAI1TLR2TERT | |
| SCHEMBL20272608 | 0.99 | GNAI3 (0.57) | GNAI3GNAO1GNAI1TLR2TERT | |
| SCHEMBL20706553 | 0.99 | GNAI3 (0.57) | GNAI3GNAO1GNAI1TLR2TERT | |
| SCHEMBL14240716 | 0.96 | GNAI3 (0.51) | GNAI3GNAO1GNAI1TLR2TERT | |
| SCHEMBL14240586 | 0.95 | GNAI3 (0.50) | GNAI3GNAO1GNAI1TLR2TERT | |
| SCHEMBL14616413 | 0.94 | GNAI3 (0.59) | GNAI3GNAO1GNAI1TLR2TERT | |
| SCHEMBL14616462 | 0.94 | GNAI3 (0.59) | GNAI3GNAO1GNAI1TLR2TERT | |
| SCHEMBL14616485 | 0.94 | GNAI3 (0.52) | GNAI3GNAO1GNAI1TLR2TERT | |
| SCHEMBL14616412 | 0.94 | GNAI3 (0.52) | GNAI3GNAO1GNAI1TLR2TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3673898-A1 | METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | Nitto Denko Corporation (JP) | 2020-07-01 | — | — | EP | claimed |
| EP-2773326-B1 | METHOD FOR STERILELY PRODUCING LIPID-NUCLEIC ACID PARTICLES | NITTO DENKO CORP (JP) | 2019-02-20 | — | — | EP | claimed |
| US-10155945-B2 | Method of producing lipid nanoparticles for drug delivery | NITTO DENKO CORPORATION (JP) | 2018-12-18 | — | — | US | claimed |
| US-20170152516-A1 | METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | NITTO DENKO CORPORATION (JP) | 2017-06-01 | — | — | US | claimed |
| EP-3673898-A1 | METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | Nitto Denko Corporation (JP) | 2020-07-01 | — | — | EP | disclosed |
| EP-3485875-A1 | SINGLE USE SYSTEM FOR STERELILY PRODUCING LIPID-NUCLEIC ACID PARTICLES | Nitto Denko Corporation (JP) | 2019-05-22 | — | — | EP | disclosed |
| EP-2773326-B1 | METHOD FOR STERILELY PRODUCING LIPID-NUCLEIC ACID PARTICLES | NITTO DENKO CORP (JP) | 2019-02-20 | — | — | EP | disclosed |
| US-10155945-B2 | Method of producing lipid nanoparticles for drug delivery | NITTO DENKO CORPORATION (JP) | 2018-12-18 | — | — | US | disclosed |
| US-20170152516-A1 | METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | NITTO DENKO CORPORATION (JP) | 2017-06-01 | — | — | US | disclosed |
| US-9579338-B2 | Method of producing lipid nanoparticles for drug delivery | NITTO DENKO CORPORATION (JP) | 2017-02-28 | — | — | US | disclosed |
| US-8956572-B2 | Single use system for sterilely producing lipid-nucleic acid particles | NITTO DENKO CORPORATION (JP) | 2015-02-17 | — | — | US | disclosed |
| US-20130164400-A1 | SINGLE USE SYSTEM FOR STERILELY PRODUCING LIPID-NUCLEIC ACID PARTICLES | NITTO DENKO CORPORATION (JP) | 2013-06-27 | — | — | US | disclosed |
| US-20130115274-A1 | METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | NITTO DENKO CORPORATION (JP) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130164400-A1 | SINGLE USE SYSTEM FOR STERILELY PRODUCING LIPID-NUCLEIC ACID PARTICLES | RNGTT, SPOUT1, NASP | GNAI3 2686/4885GNAO1 3998/4885GNAI1 2963/4885 |
| US-20130115274-A1 | METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | PHOSPHO1, LIPA, LIPC | GNAI3 2110/4885GNAO1 3930/4885GNAI1 2316/4885 |
| US-20170152516-A1 | METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | PHOSPHO1, LIPA, LIPC | GNAI3 2110/4885GNAO1 3930/4885GNAI1 2316/4885 |
| US-10155945-B2 | Method of producing lipid nanoparticles for drug delivery | PHOSPHO1, LIPA, LIPC | GNAI3 2110/4885GNAO1 3930/4885GNAI1 2316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.